Study details
Enrolling now
Positron Emission Tomography (PET) Imaging of Thrombosis
Massachusetts General Hospital
NCT IDNCT03830320ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
165
Study length
about 9.8 years
Ages
18–85
Locations
1 site in MA
What this study is about
This trial is testing a new radiotracer called 64Cu-FBP8 for PET-MR imaging to detect thrombosis. The tracer has the potential to find clots anywhere in the body, offering a non-invasive way to check for them compared to current methods.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take [64Cu]FBP8
- 2.Undergo Blood Collection
- 3.Undergo Electrocardiogram
- +1 more
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
diagnostic
Body systems
Cardiology / Heart, Oncology, Infectious